What analysts say:
- Buy, sell, or hold?: Analysts are bullish on LifePoint Hospitals, as 11 analysts rate it as a buy and only three analysts rate it as a sell. Analysts don't like LifePoint Hospitals as much as competitor HealthSouth overall. Analysts still rate the stock a hold, but they are a bit more wary about it compared with three months ago.
- Revenue forecasts: On average, analysts predict $878.4 million in revenue this quarter. That would represent a rise of 11.1% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $0.75 per share. Estimates range from $0.71 to $0.79.
What our community says:
CAPS All-Stars are solidly behind the stock, with 86.5% granting it an "outperform" rating. The community at large backs the All-Stars, with 82.7% awarding it a rating of "outperform." Fools are gung-ho about LifePoint Hospitals, though the message boards have been quiet lately with only 30 posts in the past 30 days. LifePoint Hospitals' bearish CAPS rating of two out of five stars falls short of the Fool community sentiment.
LifePoint Hospitals' profit has risen year over year by an average of 17.3%. Revenue has now gone up for three straight quarters.
For all our LifePoint Hospitals-specific analysis, including earnings and beyond, add LifePoint Hospitals to My Watchlist.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.